¿ËÈÕ£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýҽԺѬȾ¿Æ¸ßÖ¾Á¼½ÌÊÚÍŶÓÈ¡µÃ¸Î°©Î¢ÇéÐÎÑо¿·½ÃæµÄÐÂÍ»ÆÆ£¬Ñо¿Ð§¹ûÓÚ2019Äê7ÔÂ15ÈÕÔÚ¹ú¼Ê×ÅÃûÁÙ´²Ñо¿Ò½Ñ§ÔÓÖ¾Journal of Clinical Investigation£¨IF = 12.282£©½ÒÏþ£¬ÌâΪ¡°The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy¡±¡£
¸Îϸ°û¸Î°©£¨HCC£©ÊÇÏÖÔڸβ¡ÁìÓò×îÖµµÃ¹Ø×¢µÄÎÊÌâ¡£2016ÄêÌìÏÂÎÀÉú×éÖ¯£¨WHO£©¾¯Ê¾£¬ÖÁ2030ÄêÖйú½«ÓÐ1000Íò¸Î²¡»¼ÕßéæÃü£¬Æängµç×ÓÓÎÏ·²¿·ÖÓÉHCCËùµ¼Ö¡£
½üÄêÀ´£¬Ëæ×Ÿΰ©ÃâÒß΢ÇéÐÎÑо¿È¡µÃÖØ´óÏ£Íû£¬¸Î°©»ù´¡Ñо¿ºÍÁÙ´²ÖÎÁÆÒѾ±¬·¢Á˸ùÌìÐÔת±ä¡£ÀýÈ磬Õë¶ÔÃâÒßÒÖÖÆ·Ö×ÓPD-1/PD-L1µÄµ¥¿¹¿É»Ö¸´¸Î°©Î¢ÇéÐεÄÃâÒßÓ¦´ð²¢ÒÑÈ¡µÃÁîÈËÖõÄ¿µÄÁÙ´²ÁÆÐ§¡£¿ÉÊÇ£¬×ÝÈ»ÊÇÔÚÃô¸Ð£¨PD-L1+£©µÄ¸Î°©»¼ÕßÖУ¬PD-1/PD-L1¿¹ÌåÒ²Ö»¶ÔһС²¿·Ö»¼ÕßÓÐÓá£Òò´Ë£¬ÉîÈë̽ÌÖPD-L1+¸Î°©Î¢ÇéÐεÄ×é³É¡¢¡¢¡¢¹¦Ð§ÓëËÜÔì»úÖÆ£¬ÓÐÍûΪ¸Î°©µÄ¾«×¼ÃâÒßÖÎÁÆÌṩеİеã·Ö×ÓºÍиÉÔ¤Õ½ÂÔ¡£

Ñо¿·¢Ã÷PD-L1+µÄ¸Î°©ÃâÒß΢ÇéÐÎÖеľÞÊÉϸ°û±£´æ¸ß¶ÈÒìÖÊÐÔ£¬ÁªºÏÃâÒß¼ì²éµãÖÎÁƺ;ÞÊÉϸ°û¹¦Ð§µ÷¿ØÓÐÍû³ÉΪÐÂÐ͵ĸΰ©ÖÎÁÆÕ½ÂÔ
¸ßÖ¾Á¼½ÌÊÚÍŶÓÓë˫Ƹ½ÌÊÚÚ÷¶°Ã÷½ÌÊÚÍŶÓÏàÖú£¬ÔÚ¡°Ê®ÈýÎ塱¹ú¼Ò¿Æ¼¼ÖØ´óרÏîºÍ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØµãÏîÄ¿µÈ»ù½ðµÄÖ§³ÖÏ£¬·¢Ã÷ÁËPD-L1+¸Î°©ÃâÒß΢ÇéÐα£´æ¸ß¶ÈµÄÒìÖÊÐÔ¡£Ñо¿Ö¤Êµ¾ÞÊÉϸ°ûºÍTϸ°ûÊͷŵÄÑ×ÐÔ½éÖʾù¼ÓÈëÁËPD-L1+¸Î°©Ðγɣ¬µ«¾ÞÊÉϸ°ûͬʱ¸³ÓèÁËPD-L1+¸Î°©¿É·´¿¹¹Å°å»¯ÁÆ¡¢¡¢¡¢Tϸ°ûɱÉ˺ÍÃâÒß¼ì²éµãÖÎÁƵÄÌØÕ÷¡£ÁªºÏÃâÒß¼ì²éµãÖÎÁƺ;ÞÊÉϸ°û¹¦Ð§µ÷¿ØÓÐÍû³ÉΪÐÂÐ͵ĸΰ©ÖÎÁÆÕ½ÂÔ¡£Í¬Ê±£¬ÉÏÊöÖ÷ÌåÑо¿½áÂÛͬʱÔÚ¶àÖÖÈËÀàÖ×ÁöÖлñµÃÑéÖ¤¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.ncbi.nlm.nih.gov/pubmed/?term=The+local+immune+landscape+determines+tumor+PD-L1+heterogeneity+and+sensitivity+to+therapy